Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study
Jan Hillert, Meritxell Sabidó(Merck KGaA, Darmstadt (Germany)), Irene D. Bezemer(Leiden University Medical Center), Helmut Butzkueven(Monash Alfred Psychiatry Research centre), Nicholas Moore(American Sports Medicine Institute), Jan Aarseth(Haukeland University Hospital), Merja Soilu‐Hänninen(University of Turku), Jens Kühle(University of Basel), Vasili Mushnikov(IQVIA (United Kingdom)), Luigi Pontieri(Rigshospitalet), Stig Wergeland(Haukeland University Hospital), Chao Zhu(University Clinical Centre), Lars Forsberg, Melinda Magyari(University of Copenhagen), Tjalf Ziemssen(University Hospital Carl Gustav Carus), Nicholas Sicignano(Trex (United States))
Cited by 4
Related Papers
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Multiple Sclerosis Severity Score
|Neurology|2005|957
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809